Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor AP-2 epsilon (TFAP2E) is a sequence-specific DNA-binding protein that interacts with enhancer elements to regulate transcription of selected genes. It is a member of the AP-2 family of transcription factors, characterized by their role in gene regulation via RNA polymerase II. TFAP2E functions mainly in the nucleus, binding to specific DNA sequences and activating or suppressing gene expression, with key roles in development and tissue-specific gene regulation. While other AP-2 family members have established roles in cancer and development, the specific biological and pathological roles of TFAP2E are still being elucidated[3][5][2].
Transcriptional regulation by DNA binding (for potential drugs, the mechanism would likely involve modulation of its expression, DNA binding activity, or transcriptional function[3][5])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor AP-2 epsilon (TFAP2E).